68 results on '"Gupta, Divya"'
Search Results
2. Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
3. Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation
4. Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
5. Restenosis rates for drug-eluting stents used in treating small vessel cardiac allograft vasculopathy after orthotopic heart transplantation
6. Implementation of Medical Students as Radiology Reading Room Coordinators
7. Management and outcomes of heart transplant candidates with bloodstream infection on temporary mechanical circulatory support
8. Partial-Length Treatment With Brachytherapy in Patients With Endometrial Cancer With High-Risk Features Is as Effective as Full-Length Vaginal Brachytherapy but With Reduced Toxicity
9. Left Ventricular Assist Devices and Pregnancy: Systematic Review of Existing Literature and Case Report
10. Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants
11. Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial
12. Decisional regret in left ventricular assist device patient-caregiver dyads
13. Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia
14. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials
15. Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation
16. D-43 | Restenosis and Outcomes Following PCI of Small Vessels in Cardiac Transplant Recipients
17. The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice
18. Chapter 6 - Application of essential oils for the production of dietary supplements and as traditional self-medication purposes
19. Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes
20. Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure
21. P04-004-23 Capacity Building and Strengthening of Salt Iodine Monitoring Laboratories in Rural Endemic Areas of Uttar Pradesh India – Alternate Health Care Delivery
22. Cardiac Stereotactic Radiation Therapy for Refractory Ventricular Arrhythmias in Patients With Left Ventricular Assist Device
23. Current Perspectives on Hydralazine and Nitrate Therapies in Heart Failure
24. Dilated cardiomyopathy in a 32-year-old woman with Russell–Silver syndrome
25. TREATMENT OF PERSISTENT NONRESTORATIVE SLEEP DUE TO PERIODIC LIMB MOVEMENT DISORDER IN PATIENTS ON POSITIVE AIRWAY PRESSURE THERAPY FOR OBSTRUCTIVE SLEEP APNEA
26. Administration of Concurrent Vaginal Brachytherapy During Chemotherapy for Treatment of Endometrial Cancer
27. PO-01-162 DIVERGENT PATTERNS: CONTRASTING VOLTAGE AND CALCIUM ALTERNANS BETWEEN FISH AND HUMAN HEARTS
28. A CASE OF LATE PRESENTATION IMMUNE CHECKPOINT-INHIBITOR ASSOCIATED MYOCARDITIS
29. SUCCESSFUL MANAGEMENT OF SEVERE PERIPARTUM CARDIOMYOPATHY COMPLICATED BY HIGH-RISK PREGNANCY
30. PO-02-174 CHARACTERIZATION OF PAPILLARY MUSCLE ABLATION WITH OPTICAL MAPPING AT DIFFERENT TRANSMURAL PENETRATION DEPTHS IN LIVE HUMAN HEART
31. The Association Of Intra-aortic Balloon Pump Or Impella Duration Of Support With Waitlist And Post-heart Transplant Outcomes
32. Impact Of Baseline Renal Function On Waitlist Outcomes In Patients Supported With Impella As A Bridge To Transplant
33. 26 - Microwave synthesized nanocomposites for enhancing oral bioavailability of drugs
34. List of contributors
35. Efficacy of niraparib by timing of surgery and residual disease: a post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
36. Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer
37. An open-label phase II study of dostarlimab (TSR-042), bevacizumab (bev), and niraparib combination in patients (pts) with platinum-resistant ovarian cancer (PROC): cohort A of the OPAL trial
38. Transcaval TAVR on A LVAD Patient Presenting with Cardiogenic Shock
39. SEX DIFFERENCES IN ELIGIBILITY FOR ADVANCED HEART FAILURE THERAPIES
40. List of contributors
41. Prognostic Impact of Morphological Cellularity in Early Assessment Bone Marrow Biopsy after 7+3 Induction in Patients with Acute Myeloid Leukemia
42. Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized with Heart Failure: Results of the SECRET of CHF
43. The Targeting Acute Congestion with Tolvaptan in Congestive Heart Failure Study: A Randomized, Double blind, Placebo-Controlled Trial in Acute Heart Failure
44. 341 - Lower Mean LDL is Associated with Reduced Risk of Transplant Coronary Artery Vasculopathy
45. 334 - Obesity at 1 Year Post-Transplant is Associated With Increased Risk of Transplant Coronary Allograft Vasculopathy
46. 054 - Β-Blockers Improves Overall Survival during Support with Continuous-Flow Left Ventricular Assist Device
47. 053 - Low Access to Fresh Food Fails to Predict Heart Failure Outcomes
48. 026 - Do the Reasons That Patients are Ineligible for Advanced Heart Failure Therapies Vary According to Insurance Type
49. TRANSITION TO STAGE D HEART FAILURE AMONG STABLE OUTPATIENTS WITH SYSTOLIC HEART FAILURE
50. INTERMACS PROFILES AND MORTALITY AMONG AMBULATORY PATIENTS WITH SYSTOLIC HEART FAILURE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.